XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Total revenue $ 682 $ 373 $ 358
Cost of revenue 615 261 196
Gross profit 67 112 162
Operating expenses      
Research and development 20,473 11,318 8,891
Sales and marketing 3,431 1,818 1,806
General and administrative 27,240 12,913 15,708
Total operating expenses 51,144 26,049 26,405
Loss from operations (51,077) (25,937) (26,243)
Non-operating income (expense)      
Interest and other income, net 20,718 423 295
Interest expense (65) (2,496) (1,602)
Change in fair value of derivative liability 11,750 (40,532) 528
Loss before income tax provision (18,674) (68,542) (27,022)
Income tax provision
Net Loss (18,674) (68,542) (27,022)
Less: Series A convertible preferred stock dividends 861
Net loss attributable to common stockholders (18,674) (68,542) (27,883)
Other comprehensive income (loss):      
Unrealized gain on available-for-sale debt securities (net of tax) 905
Total comprehensive income (loss) $ (17,769) $ (68,542) $ (27,883)
Loss per share:      
Basic (in Dollars per share) $ (0.11) $ (0.73) $ (0.42)
Diluted (in Dollars per share) $ (0.11) $ (0.73) $ (0.42)
Weighted average shares used in computing net loss per common share:      
Basic (in Shares) 164,492 93,881 66,611
Diluted (in Shares) 164,492 93,881 66,611